Retatrutide / Reta — 30 mg

Retatrutide, also known as Reta, is a research peptide studied for its activity across incretin and glucagon-related receptor pathways, including GLP-1, GIP and glucagon receptor signalling. Supplied as a 30 mg lyophilised peptide, it is suited for analytical and laboratory-based research purposes only. Retatrutide remains an investigational compound under clinical study.

For laboratory research use only. Not for human or veterinary use.